(2026). Real-world outcomes after switching to faricimab in treatment-resistant diabetic macular edema: A 1-year observational study with choroidal thickness assessment. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Real-world Outcomes After Switching to Faricimab in Treatment-resistant Diabetic Macular Edema: A 1-year Observational Study with Choroidal Thickness Assessment."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Real-world Outcomes After Switching to Faricimab in Treatment-resistant Diabetic Macular Edema: A 1-year Observational Study with Choroidal Thickness Assessment."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.